Discover 921 paid clinical trials in Hillsboro, Oregon. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 921
A Study of Neoadjuvant Amivantamab With Either Lazertinib or Chemotherapy in Participants With Resectable EGFR-Mutated NSCLC
for
Carcinoma, Non-Small-Cell Lung
Location: Portland OR, Duarte CA, Irvine CA, Toronto
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07586202
Phase2, Recruiting
IGNITE: Study of Tirabrutinib vs Rituximab/Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL)
for
Relapsed/Refractory Primary Central Nervous System Lymphoma
Location: Portland OR, Seattle WA, Fullerton CA, Orange CA,
Sponsor: Ono Pharmaceutical Co., Ltd.
Sex: All
Age: 18+
Code: NCT07104032
Phase3, Recruiting
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
for
Lymphoma, Large B-Cell, Diffuse
Location: Portland OR, Vancouver WA, Post Falls ID,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06890884
Phase2, Recruiting
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
for
Relapsing Multiple Sclerosis
Location: Portland OR, Vancouver, Edmonton, Las Vegas NV,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 40 - 70
Code: NCT06846281
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F)
for
Lung Neoplasm Malignant
Location: Portland OR, Chicago IL, Clermont FL
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07286149
Phase1, Phase2, Recruiting
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
for
Relapsed Hematologic Malignancy,
Location: Portland OR, Seattle WA, Salt Lake City UT,
Sponsor: Curis, Inc.
Sex: All
Age: 18+
Code: NCT03328078
Phase1, Phase2, Recruiting
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
for
Psychosis Associated With Alzheimer's Disease
Location: Tigard OR, Bellevue WA, Las Vegas NV, Long Beach CA,
Sponsor: MapLight Therapeutics
Sex: All
Age: 55 - 70+
Code: NCT06887192
Phase2, Recruiting
A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)
for
Generalized Myasthenia Gravis
Location: Tigard OR, San Francisco CA, Los Angeles CA, Orange CA,
Sponsor: Vor Biopharma
Sex: All
Age: 18+
Code: NCT06456580
Phase3, Recruiting
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
for
Migraine
Location: Portland OR, Seattle WA, Reno NV, Walnut Creek CA,
Sponsor: Kallyope Inc.
Sex: All
Age: 18 - 70+
Code: NCT07645924
Phase3, Recruiting
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
for
Chronic Idiopathic Constipation (CIC)
Location: Tigard OR, Boise ID, Reno NV, Lincoln CA, Blackfoot ID,
Sponsor: Ardelyx
Sex: All
Age: 18 - 70+
Code: NCT07382167
Phase3, Recruiting
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
for
Acute Migraine
Location: Portland OR, Seattle WA, Reno NV, Walnut Creek CA,
Sponsor: Kallyope Inc.
Sex: All
Age: 18+
Code: NCT07674654
Phase3, Recruiting
Multi-Center, Prospective, Non-Interventional Study in Subjects With Limbal Stem Cell Deficiency
for
Limbal Stem Cell Deficiency
Location: Portland OR, Minnetonka MN, Overland Park KS,
Sponsor: Claris Biotherapeutics, Inc.
Sex: All
Age: 12 - 70+
Code: NCT07636590
Recruiting
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
Location: Portland OR, Burien WA, Surrey, Vancouver, Lancaster CA,
Sponsor: Inmagene LLC
Sex: All
Age: 18 - 70+
Code: NCT07037901
Phase2, Recruiting
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
for
Parkinson Disease
Location: Portland OR, Bellevue WA, Los Angeles CA, Aurora CO,
Sponsor: Biohaven Therapeutics Ltd.
Sex: All
Age: 40 - 70+
Code: NCT06976268
Phase2, Phase3, Recruiting
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer